Westfield Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $3.29M | Sell |
|
|||||
|
2022
Q1 | $6.72M | Sell |
|
|||||
|
2021
Q4 | $5.93M | Sell |
|
|||||
|
2021
Q3 | $5.68M | Buy |
|
|||||
|
2021
Q2 | $6.38M | Sell |
|
|||||
|
2021
Q1 | $23M | Sell |
|
|||||
|
2020
Q4 | $114M | Sell |
|
|||||
|
2020
Q3 | $123M | Buy |
|
|||||
|
2020
Q2 | $113M | Sell |
|
|||||
|
2020
Q1 | $107M | Buy |
|
|||||
|
2019
Q4 | $97.4M | Sell |
|
|||||
|
2019
Q3 | $84.9M | Sell |
|
|||||
|
2019
Q2 | $99.4M | Sell |
|
|||||
|
2019
Q1 | $156M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $90.9M | Buy |
|
|||||
|
2018
Q2 | $68.5M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $62.6M | Sell |
|
|||||
|
2016
Q4 | $141M | Sell |
|
|||||
|
2016
Q3 | $138M | Sell |
|
|||||
|
2016
Q2 | $200M | Sell |
|
|||||
|
2016
Q1 | $199M | Buy |
|
|||||
|
2015
Q4 | $201M | Buy |
|
|||||
|
2015
Q3 | $7.72M | Sell |
|
|||||
|
2015
Q2 | $8.76M | Buy |
|
|||||
|
2015
Q1 | $5.7M | Buy |
|
|||||
|
2014
Q4 | $3.88M | Sell |
|
|||||
|
2014
Q3 | $4.62M | Buy |
|
|||||
|
2014
Q2 | $4.16M | Sell |
|
|||||
|
2014
Q1 | $186M | Sell |
|
|||||
|
2013
Q4 | $194M | Sell |
|
|||||
|
2013
Q3 | $205M | Buy |
|
|||||
|
2013
Q2 | $163M | Buy |
|